| PERIOD ENDING | 12-Sep-09 | 20-Jun-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 2,065,061 | 2,790,243 | 2,289,931 | 2,120,954 | | Cost of Revenue | 1,441,703 | 1,945,374 | 1,582,409 | 1,460,569 | | | Gross Profit | 623,358 | 844,869 | 707,522 | 660,385 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 631,924 | 846,705 | 756,785 | 648,476 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,566) | (1,836) | (49,263) | 11,909 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,028) | (1,834) | 2,633 | 22,863 | | Earnings Before Interest And Taxes | (15,594) | (3,670) | (46,630) | 34,772 | | Interest Expense | 48,559 | 54,248 | 37,516 | 36,727 | | Income Before Tax | (64,153) | (57,918) | (84,146) | (1,955) | | Income Tax Expense | (1,994) | 386 | (777) | 1,038 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (62,159) | (58,304) | (83,369) | (2,993) | | | Non-recurring Events | | Discontinued Operations | (18,150) | (6,856) | (27,759) | (10,635) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (80,309) | (65,160) | (111,128) | (13,628) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($80,309) | ($65,160) | ($111,128) | ($13,628) |
|
0.51% Nasdaq 
Income Statement
